Pharmaceuticals & Medical Products


How pharma companies can better understand patients

– Consumers have access to more healthcare information than ever. Here’s how pharmaceutical companies can better understand the way people make decisions about their care.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights


How pharma can win in a digital world

– The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and... what they do to stay ahead.

The role of big data in medicine

– Technology is revolutionizing our understanding and treatment of disease, says the founding director of the Icahn Institute for... Genomics and Multiscale Biology at New York’s Mount Sinai Health System.

Improving healthcare while curbing cost: Med-tech companies offer a solution

– Research tells us that the potential value of partnering with med-tech companies is great. Yet many hospital executives are still... not fully satisfied.

The road to digital success in pharma

– Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires... identifying the right initiatives.

Capturing returns in healthcare

– New research finds that the healthcare sector has been very good to private equity, especially payor and pharmaceutical services.... And specialist firms seem to have an edge over generalists.

Pharma’s next challenge

– Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus... to an access-driven commercial model must occur.

Africa: A continent of opportunity for pharma and patients

– Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving... that strength and how companies should react.

Novartis on digitizing medicine in an aging world

– CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.

AMNOG revisited

– AMNOG is here to stay. Pharma companies will have to learn to live with an unpredictable market-access process. With planning... and learning from the experiences to date, success in Germany is possible.

Maintaining momentum in Brazil’s pharmaceutical market

– Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit... growth is possible, but will require a granular approach.

Capturing the new ‘value’ segment in medical devices

– The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers... to develop strategies to attract and retain this new segment of customers.

Connect with our Pharmaceuticals & Medical Products Practice

McKinsey Insights App

Our latest thinking at your fingertips.
Anytime. Anywhere.

or continue to site